The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2 trial of ABVD followed by brentuximab vedotin consolidation in limited stage non-bulky Hodgkin lymphoma.
 
Steven I. Park
Research Funding - Seagen; Teva
Travel, Accommodations, Expenses - Janssen
 
Oludamilola A. Olajide
No Relationships to Disclose
 
Nishitha M. Reddy
Consulting or Advisory Role - Abbvie; Celgene; Seagen
 
L. Elizabeth Budde
No Relationships to Disclose
 
Nilanjan Ghosh
Consulting or Advisory Role - Abbvie; Celgene; Janssen; Seagen
Speakers' Bureau - Celgene; Gilead Sciences; Janssen
Research Funding - Bristol-Myers Squibb; Genentech; Janssen; Millennium; Pharmacyclics; Seagen; TG Therapeutics
 
Kristy L. Richards
No Relationships to Disclose
 
Allison Mary Deal
No Relationships to Disclose
 
Jeanne F. Noe
No Relationships to Disclose
 
Thomas C. Shea
No Relationships to Disclose
 
Stephen Maxted Ansell
Honoraria - Research to Practice; WebMD
Research Funding - Bristol-Myers Squibb (Inst); Celldex (Inst); Seagen (Inst)